Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-959"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-11-24"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"it"^^xsd:language2
lpv:document identification number	"en.20101124.15.3-959"2
lpv:hasSubsequent	lp_eu:2010-11-24-Speech-3-1922
lpv:speaker	lp:Aldo Patriciello2
lpv:spokenAs	member; CONT (2009-07-16--2012-01-18)3 member; ITRE (2009-07-16--2012-01-18)3 substitute; REGI (2009-07-16--2012-01-18)3 substitute; Delegation to the Euronest Parliamentary Assembly (2009-09-16--2014-06-30)3 substitute; Delegation to the EU-Armenia, EU-Azerbaijan and EU-Georgia Parliamentary Cooperation Committees (2009-09-16--2014-06-30)3 unknown; Il Popolo della Libertà (2009-07-14--2013-12-05)3 member; Delegation for relations with Albania, Bosnia and Herzegovina, Serbia, Montenegro and Kosovo (2009-09-16--2014-06-30)3 member; EPP (2009-07-14--2014-06-30)3
lpv:translated text	"I would like to thank Mr Fjellner for his excellent work. I voted in favour because I agree that non-promotional information on medicinal products must be made available to patients and the general public by marketing authorisation holders according to the ‘pull principle’ whereby patients/the public have access to information if they need it, contrary to the ‘push principle’ whereby the marketing authorisation holders disseminate information among patients and the general public."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph